ADAMTS9 and breast carcinoma: The results revealed that the invasion (p < 0.05) as well as proliferation (p < 0.05) of breast cancer were markedly boosted after the downregulation of ADAMTS9-AS1 expression, while these abilities reversed upon co-transfection with si-ADAMTS9-AS1 and miR-301b-3p inhibitor.